Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis

Physiological Reports

Volumn 3, Issue 4, 2015, Pages

  Pham, Bao Tung ^a   van Haaften, Wouter Tobias ^a   Oosterhuis, Dorenda ^a   Nieken, Judith ^b   de Graaf, Inge Anne Maria ^a   Olinga, Peter ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Pathology Laboratory Friesland   (Netherlands)

Author keywords

Ex vivo model; Intestinal fibrosis; Precisioncut intestinal slice

Indexed keywords

FIBRONECTIN; HEAT SHOCK PROTEIN 47; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOLLAGEN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INTESTINAL FIBROSIS; MALE; MOUSE; NONHUMAN; PANCREATICODUODENECTOMY; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 85003726526     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12323     Document Type: Article

References (46)

1. Basaranoglu, M., G. Basaranoglu, and H. Sent € urk. 2013. From fatty liver to fibrosis: a tale of “second hit”. World J. Gastroenterol. 19:1158–1165.
2. Bianciardi, P., R. Scorza, G. Ghilardi, and M. Samaja. 2004. Xanthine oxido-reductase activity in ischemic human and rat intestine. Free Radic. Res. 38:919–925.
3. Brigstock, D. R. 2010. Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J. Cell Commun. Signal. 4:1–4.
4. Cassiman, D., J. van Pelt, R. De Vos, F. Van Lommel, V. Desmet, S. H. Yap, et al. 1999. Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am. J. Pathol. 155:1831–1839.
5. De Graaf, I.A., P. Olinga, de Jager M. H., M. T. Merema, de Kanter R., devan Kerkhof E. G., et al. 2010. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat. Protoc. 5:1540–1551.
6. Dendooven, A., K. G. Gerritsen, T. Q. Nguyen, R. J. Kok, and R. Goldschmeding. 2011. Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers 16:289–301.
7. Fiocchi, C., and P. K. Lund. 2011. Themes in fibrosis and gastrointestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G677–G683.
8. Froehlich, F., P. Juillerat, C. Mottet, C. Felley, J.-P. Vader, B. Burnand, et al. 2005. Obstructive fibrostenotic Crohn’s disease. Digestion 71:29–30.
9. de Graaf, I. A., G. M. Groothuis, and P. Olinga. 2007. Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opin. Drug Metab. Toxicol. 3:879–898.
10. Honzawa, Y., H. Nakase, Y. Takeda, K. Nagata, and T. Chiba. 2010. Heat shock protein 47 can be a new target molecule for intestinal fibrosis related to inflammatory bowel disease. Inflamm. Bowel Dis. 16:2004–2006.
11. Honzawa, Y., H. Nakase, M. Shiokawa, T. Yoshino, H. Imaeda, M. Matsuura, et al. 2014. Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn’s disease. Gut 63:1902–1912.
12. Khan A.A., E. C. Y. Chow, vanLoenen-Weemaes A. M., R. J. Porte, K. S. Pang, and G. M. M. Groothuis. 2009. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur. J. Pharm. Sci. 37:115–125.
13. Khan, A. A., B. S. Dragt, R. J. Porte, and G. M. M. Groothuis. 2010. Regulation of VDR expression in rat and human intestine and liver–consequences for CYP3A expression. Toxicol. In Vitro 24:822–829.
14. Kidd, M., I. M. Modlin, M. D. Shapiro, R. L. Camp, S. M. Mane, W. Usinger, et al. 2007. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J. Gastroenterol. 13:5208–5216.
15. Kitamura, H., S. Yamamoto, H. Nakase, M. Matsuura, Y. Honzawa, K. Matsumura, et al. 2011. Role of heat shock protein 47 in intestinal fibrosis of experimental colitis. Biochem. Biophys. Res. Commun. 404:599–604.
16. Kropski, J.A., W. E. Lawson, and T. S. Blackwell. 2012. Right place, right time: the evolving role of herpesvirus infection as a “second hit” in idiopathic pulmonary fibrosis. AJP Lung Cell. Mol. Physiol. 302:L441–L444.
17. Kuang, P-P., X-H. Zhang, C. B. Rich, J. A. Foster, M. Subramanian, and R. H. Goldstein. 2007. Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L944–L952.
18. Kutz, S. M., J. Hordines, P. J. McKeown-Longo, and P. J. Higgins. 2001. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J. Cell Sci. 114:3905–3914.
19. Latella, G., R. Sferra, S. Speca, A. Vetuschi, and E. Gaudio. 2013. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Eur. Rev. Med. Pharmacol. Sci. 17:1283–1304.
20. Li, D., and S. L. Friedman. 1999. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol. 14:618–633.
21. Louis, E., A. Collard, A. F. Oger, E. Degroote, F. A. Aboul Nasr El Yafi, and J. Belaiche. 2001. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49:777–782.
22. Lund, P. K., and R. J. Rigby. 2008. What are the mechanisms of fibrosis in IBD? Inflamm. Bowel Dis. 14(Suppl 2):S127–S128.
23. Niu, X., deGraaf I. A., and G. M. M. Groothuis. 2013. Evaluation of the intestinal toxicity and transport of xenobiotics utilizing precision-cut slices. Xenobiotica 43:73–83.
24. Park, P. O., U. Haglund, G. B. Bulkley, and K. F € alt. 1990. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 107:574–580.
25. Possidente, M., S. Dragoni, G. Franco, M. Gori, E. Bertelli, E. Teodori, et al. 2011. Rat intestinal precision-cut slices as an in vitro model to study xenobiotic interaction with transporters. Eur. J. Pharm. Biopharm. 79:343–348.
26. Rhyu, D. Y., Y. Yang, H. Ha, G. T. Lee, J. S. Song, S. Uh, et al. 2005. Role of reactive oxygen species in TGF-beta1- induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol. 16:667–675.
27. Rieder, F., and C. Fiocchi. 2008. Intestinal fibrosis in inflammatory bowel disease–current knowledge and future perspectives. J. Crohns. Colitis 2:279–290.
28. Rieder, F., and C. Fiocchi. 2009. Intestinal fibrosis in IBD–a dynamic, multifactorial process. Nat. Rev. Gastroenterol. Hepatol. 6:228–235.
29. Rieder, F., J. Brenmoehl, S. Leeb, J. Sch € olmerich, and G. Rogler. 2007. Wound healing and fibrosis in intestinal disease. Gut 56:130–139.
30. Rieder, F., S. Kessler, M. Sans, and C. Fiocchi. 2012. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am. J. Physiol. Gastrointest. Liver Physiol. 303:G786–G801.
31. Roskott, A. M., V. B. Nieuwenhuijs, H. G. D. Leuvenink, G. Dijkstra, P. Ottens, deJager M. H., et al. 2010. Reduced ischemia-reoxygenation injury in rat intestine after luminal preservation with a tailored solution. Transplantation 90:622–629.
32. Silverstein, M. D., E. V. Loftus, W. J. Sandborn, W. J. Tremaine, B. G. Feagan, P. J. Nietert, et al. 1999. Clinical course and costs of care for Crohn’s disease: Markov model analysis of a population-based cohort. Gastroenterology 117:49–57.
33. Smith, P. D., L. E. Smythies, R. Shen, T. Greenwell-Wild, M. Gliozzi, and S. M. Wahl. 2011. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 4:31–42.
34. Taguchi, T., and M. S. Razzaque. 2007. The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? Trends Mol. Med. 13:45–53.
35. Taguchi, T., A. Nazneen, A. A. Al-Shihri, K. A. Turkistani, and M. S. Razzaque. 2011. Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells. Acta Histochem. Cytochem. 44:35–41.
36. To, W. S., and K. S. Midwood. 2011. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogen. Tissue Rep. 4:21.
37. Van de Bovenkamp, M., G. M. M. Groothuis, D. K. F. Meijer, M. J. H. Slooff, and P. Olinga. 2006. Human liver slices as an in vitro model to study toxicity-induced hepatic stellate cell activation in a multicellular milieu. Chem. Biol. Interact. 162:62–69.
38. Van De Kerkhof, E.G., L. B. Ungella, A. K. Sj € oberg, M. H. De Jager, C. Hilgendorf, I. A. M. De Graaf, et al. 2006. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with Ussing chamber preparations. Drug Metab. Dispos. 34:1893–1902.
39. Van de Kerkhof, E. G., I. A. M. de Graaf, M. H. de Jager, and G. M. M. Groothuis. 2007. Induction of phase I and II drug metabolism in rat small intestine and colon in vitro. Drug Metab. Dispos. 35:898–907.
40. Van de Kerkhof, E. G., I. A. M. de Graaf, A.-L. B. Ungell, and G. M. M. Groothuis. 2008. Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro. Drug Metab. Dispos. 36:604–613.
41. Vickers, A. E. M., and R. L. Fisher. 2005. Precision-cut organ slices to investigate target organ injury. Expert Opin. Drug Metab. Toxicol. 1:687–699.
42. Westra, I. M., D. Oosterhuis, G. M. Groothuis, and P. Olinga. 2011. Induction of fibrotic markers in an in vitro model of liver fibrosis. Hepatology 54:754A–755A.
43. Westra, I. M., B. T. Pham, G. M. M. Groothuis, and P. Olinga. 2013. Evaluation of fibrosis in precision-cut tissue slices. Xenobiotica 43:98–112.
44. Westra, I. M., D. Oosterhuis, G. M. M. Groothuis, and P. Olinga. 2014a. The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices. PLoS ONE 9:e95462.
45. Westra, I. M., D. Oosterhuis, G. M. M. Groothuis, and P. Olinga. 2014b. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol. Appl. Pharmacol. 274:328–338.
46. Yan, F., Y. Wang, X. Wu, H. M. Peshavariya, G. J. Dusting, M. Zhang, et al. 2014. Nox4 and redox signaling mediate TGF-b-induced endothelial cell apoptosis and phenotypic switch. Cell Death Dis. 5:e1010.